Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial

[1]  G. Hofmeyr,et al.  Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomized trial , 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[2]  Douglas J. Taylor,et al.  HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial , 2019, The Lancet.

[3]  K. Ghanem,et al.  Risk of Gonococcal Infection During Vaginal Exposure is Associated With High Vaginal pH and Active Menstruation , 2019, Sexually transmitted diseases.

[4]  S. Sanders,et al.  Decision making over condom use during menses to avert sexually transmissible infections. , 2019, Sexual health.

[5]  G. Samonis,et al.  Is Vaginal Sexual Intercourse Permitted during Menstruation? A Biblical (Christian) and Medical Approach. , 2018, Maedica.

[6]  J. Hapgood,et al.  Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels , 2018, PloS one.

[7]  Moazzam Ali,et al.  Expanding Method Choice in Africa with Long-Acting Methods: IUDs, Implants or Both? , 2017, International perspectives on sexual and reproductive health.

[8]  K. Curtis,et al.  An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women , 2016, AIDS.

[9]  T. Lawrie,et al.  Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial , 2016, Reproductive Health.

[10]  B. Kaur,et al.  Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection , 2016, Mucosal Immunology.

[11]  T. Lawrie,et al.  Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. , 2015, The lancet. HIV.

[12]  K. Smith-McCune,et al.  Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. , 2015, The lancet. HIV.

[13]  C. Schooling.  Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. , 2015, The lancet. HIV.

[14]  J. Baeten,et al.  Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. , 2015, The lancet. HIV.

[15]  C. Morrison,et al.  Hormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis , 2015, PLoS medicine.

[16]  T. Lawrie,et al.  Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk. , 2014, Contraception.

[17]  M. Gibbs,et al.  Menstrual Taboos Among Major Religions , 2007 .

[18]  S. Kalichman,et al.  Coital Bleeding and HIV Risks Among Men and Women in Cape Town, South Africa , 2006, Sexually transmitted diseases.

[19]  C. Cheng‐Mayer,et al.  Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. , 2006, Virology.

[20]  S. Kalichman,et al.  Sexual exposure to blood and behavioural risks among STI clinic patients in Cape Town, South Africa. , 2005, Sexual health.

[21]  S. Kalichman,et al.  Sexual exposure to blood and increased risks for heterosexual HIV transmission in Cape Town, South Africa. , 2004, African journal of reproductive health.

[22]  B. Nowicki,et al.  Susceptibility to gonococcal infection during the menstrual cycle. , 2000, JAMA.

[23]  K. Holmes,et al.  Migration, ethnicity and environment: HIV risk factors for women on the sugar cane plantations of the Dominican Republic , 1998, AIDS.

[24]  D. Ho,et al.  Progesterone implants enhance SIV vaginal transmission and early virus load , 1996, Nature Medicine.

[25]  S. Aral,et al.  Sexual Intercourse During Menstruation and Self‐Reported Sexually Transmitted Disease History Among Women , 1996, Sexually transmitted diseases.

[26]  R. Hatcher.  Counseling couples about coitus during menstrual flow. , 1981, Contraceptive technology update.